The emerging practice of combining kratom, a legal botanical, with pain reliever – often referred to as "Kratom Lean" – presents a complex legal ambiguity. At present, the federally regulated status of kratom stays in flux, varying significantly by state and localities, while codeine’s controlled

Research compounds, often described "novel psychoactive materials," present a considerable challenge due to their rapid nature. These substances are typically synthesized for academic exploration, but are frequently encountered in the recreational drug market. The absence of extensive data on the

The concerning trend is appearing among users: the simultaneous ingestion of legal lean syrup – often containing DXM – and kratom, a Southeast Asian plant.

This hazardous alliance presents grave health risks. Both substances independently carry considerable hazard, but their combined effect ca